These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1009582)

  • 21. Characterization of suppressor cells in mice bearing syngeneic mastocytoma.
    Takei F; Levy JG; Kilburn DG
    J Immunol; 1977 Feb; 118(2):412-7. PubMed ID: 65423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative in vitro immunogenicity of cultured murine islets and hepatocytes.
    Meloche M; Bumgardner G; Stock P; Chen S; Ascher NL; Sutherland DE
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2682-4. PubMed ID: 2523160
    [No Abstract]   [Full Text] [Related]  

  • 23. The genetic control of T cell-meditated immunity. I. Characterization of a mouse strain whose low responsiveness is inherited as a recessive trait.
    Vachek H; Kölsch E
    Immunology; 1974 Oct; 27(4):507-15. PubMed ID: 4215740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo regulation of humoral and cellular immune responses of mice by a synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine, muramyl dipeptide for MDP.
    Leclerc C; Juy D; Bourgeois E; Chedid L
    Cell Immunol; 1979 Jun; 45(1):199-206. PubMed ID: 313275
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on antilymphocytic autoimmune reactions in L1210 bearing mice.
    Devlin RG; Baugh LE; McCurdy JD; Baronowsky PE
    Cell Immunol; 1975 May; 17(1):156-64. PubMed ID: 123826
    [No Abstract]   [Full Text] [Related]  

  • 26. Regulatory mechanisms in cell-mediated immune responses. III. Antigen-specific and nonspecific suppressor activities generated during MLC.
    Hodes RJ; Nadler LM; Hathcock KS
    J Immunol; 1977 Sep; 119(3):961-7. PubMed ID: 70480
    [No Abstract]   [Full Text] [Related]  

  • 27. Generation of cytotoxic T lymphocytes in vitro. VII. Suppressive effect of irradiated MLC cells on CTL response.
    Fitch FW; Engers HD; Cerottini JC; Bruner KT
    J Immunol; 1976 Mar; 116(3):716-23. PubMed ID: 56399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effector mechanisms in allograft rejection. I. Assembly of "sponge matrix" allografts.
    Roberts PJ; Häyry P
    Cell Immunol; 1976 Oct; 26(2):160-7. PubMed ID: 975249
    [No Abstract]   [Full Text] [Related]  

  • 29. Antigen-specific T cell-mediated suppression. IV. Role of macrophages in generation of L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT)-specific suppressor T cells in responder mouse strains.
    Pierres M; Germain RN
    J Immunol; 1978 Oct; 121(4):1306-14. PubMed ID: 81227
    [No Abstract]   [Full Text] [Related]  

  • 30. Cell-mediated allograft responses in vitro. VI. Studies on macrophage-mediated cytotoxicity.
    Pfizenmaier K; Trostmann H; Röllinghoff M; Wagner H
    Immunology; 1975 Dec; 29(6):967-76. PubMed ID: 1081494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-mediated immunity to H-2 antigens. Characteristics of the effector cells as detected in the microcytotoxicity assay.
    Trostmann H; Pfizenmaier K; Wagner H; Röllinghoff M
    Transplantation; 1976 Jun; 21(6):446-53. PubMed ID: 1084606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cell-mediated immune response to ectromelia virus infection. II. Secondary response in vitro and kinetics of memory T cell production in vivo.
    Gardner ID; Blanden RV
    Cell Immunol; 1976 Mar; 22(2):283-96. PubMed ID: 179718
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity.
    Evans R; Alexander P
    Immunology; 1972 Oct; 23(4):615-26. PubMed ID: 5084104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Separable populations of activated thymus-derived lymphocytes identified in two assays for cell-mediated immunity to murine tumor allografts.
    Tigelaar RE; Gorczynski RM
    J Exp Med; 1974 Jul; 140(1):267-89. PubMed ID: 4545897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-mediated immune response in vitro. IV. Metabolic studies on cellular immunogenicity.
    Wagner H
    Eur J Immunol; 1973 Feb; 3(2):84-9. PubMed ID: 4715668
    [No Abstract]   [Full Text] [Related]  

  • 36. Cellular origins of co-stimulator (IL2) and its activity in cytotoxic T lymphocyte responses.
    Shaw J; Caplan B; Paetkau V; Pilarski LM; Delovitch TL; McKenzie IF
    J Immunol; 1980 May; 124(5):2231-9. PubMed ID: 6965968
    [No Abstract]   [Full Text] [Related]  

  • 37. Mouse mixed lymphocyte reactions and cell-mediated lympholysis: genetic control and relevance to antigenic strength.
    Abbasi K; Démant P; Festenstein H; Holmes J; Huber B; Rychiková M
    Transplant Proc; 1973 Dec; 5(4):1329-37. PubMed ID: 4149544
    [No Abstract]   [Full Text] [Related]  

  • 38. Allograft-infiltrating killer cells.
    Häyry P; Roberts PJ
    Transplant Proc; 1977 Mar; 9(1):691-3. PubMed ID: 68599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of polyunsaturated fatty acids on skin allograft survival and primary and secondary cytotoxic response in mice.
    Mertin J
    Transplantation; 1976 Jan; 21(1):1-4. PubMed ID: 1108321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cell-mediated immune response to ectromelia virus infection. I. Kinetics and characteristics of the primary effector T cell response in vivo.
    Blanden RV; Gardner ID
    Cell Immunol; 1976 Mar; 22(2):271-82. PubMed ID: 58730
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.